> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Eugia Recalls Methocarbamol Injection Lot
- URL: https://www.fdaweb.com/eugia-recalls-methocarbamol-injection-lot/
- Published: 2024-03-28T12:00:00.000Z
- Updated: 2026-09-14T14:26:46.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5156657

Eugia U.S. has recalled one lot (# 3MC23011) of methocarbamol injection, USP 1,000 mg/10 mL single-dose vial due to a customer product complaint about the presence of white particles floating inside a vial. “Administration of an injectable product that contains particulate matter may result in local irritation or swelling,” a [recall notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eugia-us-llc-fka-auromedics-pharma-llc-issues-voluntary-nationwide-recall-methocarbamol-injection?utm%5Fmedium=email&utm%5Fsource=govdelivery) says. “If the particulate matter reaches the blood vessels or is injected intravascularly it can travel to various organs and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death.” To date, Eugia says it has not received any adverse event reports related to the recall. Methocarbamol is used as an adjunct to rest, physical therapy, and other measures for relieving discomfort associated with acute, painful musculoskeletal conditions.